Tracers for sympathetic cardiac neurotransmission imaging

Autonomic Innervation of the Heart: Role of Molecular Imaging

Volumn , Issue , 2015, Pages 87-109

  Thackeray, James T ^a   DaSilva, Jean N ^b   Elsinga, Philip H ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEURONS; NOREPINEPHRINE; PARTICLE BEAMS; POSITRON EMISSION TOMOGRAPHY; PROTEINS; RADIOACTIVE TRACERS; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ADENOSINE MONOPHOSPHATE; CARDIO-VASCULAR DISEASE; CLINICAL APPLICATION; MULTI-TRACER APPROACH; NEURONAL TRANSMISSION; POSITRON EMISSION TOMOGRAPHY (PET); SECOND MESSENGER SYSTEMS; SYMPATHETIC NERVOUS SYSTEMS;

MOLECULAR IMAGING;

EID: 84943389377     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-662-45074-1_5     Document Type: Chapter

References (95)

1. Ardell JL (2004) Intrathoracic neuronal regulation of cardiac function. In: Armour JA, Ardell JL (eds) Basic and clinical neurocardiology. Oxford University Press, New York
2. Armour JA (2004) Cardiac neuronal hierarchy in health and disease. Am J Physiol Regul Integr Comp Physiol 287:R262-R271
3. Backs J, Haunstetter A, Gerber SH, Metz J, Borst MM, Strasser RH, Kubler W, Haass M (2001) The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J Mol Cell Cardiol 33:461-472
4. Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parizek P, Agostini D, Knuuti J, Flotats A, Arrighi J, Muxi A, Alibelli MJ, Banerjee G, Jacobson AF (2008) 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging 1:131-140
5. Benediktsdottir VE, Curvers J, Gudbjarnason S (1999) Time course of alterations in phospholipid fatty acids and number of beta-adrenoceptors in the rat heart during adrenergic stimulation in vivo. J Mol Cell Cardiol 31:1105-1115
6. Blanes-Mira C, Pastor MT, Valera E, Fernandez-Ballester G, Merino JM, Gutierrez LM, Perez-Paya E, Ferrer-Montiel A (2003) Identification of SNARE complex modulators that inhibit exocytosis from an alpha-helix-constrained combinatorial library. Biochem J 375:159-166
7. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ (2010) Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 55:2769-2777
8. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergicreceptor density in failing human hearts. N Engl J Med 307:205-211
9. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S et al (1986) Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 59:297-309
10. Brodde OE (1991) Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242
11. Bryan-Lluka LJ, Paczkowski FA, Bonisch H (2001) Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter. Neuropharmacology 40:607-617
12. Chida M, Kagaya Y, Imahori Y, Namiuchi S, Fujii R, Fukuchi M, Takahashi C, Tezuka F, Ido T, Shirato K (2000) Visualization of myocardial phosphoinositide turnover with 1-[1-(11) C]-butyryl-2-palmitoyl-rac-glycerol in rats with myocardial infarction. J Nucl Med 41:2063-2068
13. Dae MW, O'Connell JW, Botvinick EH, Chin MC (1995) Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 30:270-280
14. de Jong RM, Willemsen AT, Slart RH, Blanksma PK, van Waarde A, Cornel JH, Vaalburg W, van Veldhuisen DJ, Elsinga PH (2005) Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C] CGP12388. Eur J Nucl Med Mol Imaging 32:443-447
15. Degrado TR, Zalutsky MR, Vaidyanathan G (1995) Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart. Nucl Med Biol 22:1-12
16. Delforge J, Syrota A, Lancon JP, Nakajima K, Loc'h C, Janier M, Vallois JM, Cayla J, Crouzel C (1991) Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med 32:739-748
17. Denn MJ, Stone HL (1976) Autonomic innervation of dog coronary arteries. J Appl Physiol 41:30-35
18. Ding YS, Lin KS, Logan J, Benveniste H, Carter P (2005) Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S, S) and (R, R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine. J Neurochem 94:337-351
19. Elsinga PH, Doze P, van Waarde A, Pieterman RM, Blanksma PK, Willemsen AT, Vaalburg W (2001) Imaging of beta-adrenoceptors in the human thorax using (S)-[(11)C]CGP12388 and positron emission tomography. Eur J Pharmacol 433:173-176
20. Esler M, Jackman G, Leonard P, Skews H, Bobik A, Korner P (1981) Effect of norepinephrine uptake blockers on norepinephrine kinetics. Clin Pharmacol Ther 29:12-20
21. Esler MD, Jennings GL, Johns J, Burke F, Little PJ, Leonard P (1984) Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. J Hypertens Suppl 2:S123-S125
22. Fallavollita JA, Heavey BM, Luisi AJ, Michalek SM, Baldwa S, Mashtare TL, Hutson AD, deKemp RA, Haka MS, Sajid M, Cimato TR, Curtis AB, Cain ME, Canty JA (2013) Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 63:141-149
23. Foley KF, Van Dort ME, Sievert MK, Ruoho AE, Cozzi NV (2002) Stereospecific inhibition of monoamine uptake transporters by meta-hydroxyephedrine isomers. J Neural Transm 109:1229-1240
24. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H (1996) Functional beta3-adrenoceptor in the human heart. J Clin Invest 98:556-562
25. Geerlings A, Lopez-Corcuera B, Aragon C (2000) Characterization of the interactions between the glycine transporters GLYT1 and GLYT2 and the SNARE protein syntaxin 1A. FEBS Lett 470(1):51-54.
26. Gerson MC, Caldwell JH, Ananthasubramaniam K, Clements IP, Henzlova MJ, Amanullah A, Jacobson AF (2011) Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Circ Cardiovasc Imaging 4:87-93
27. Greene M, Thackeray JT, Kenk M, Thorn SL, Bevilacqua L, Harper M-E, Beanlands RS, DaSilva JN (2009) Reduced In Vivo Phosphodiesterase-4 Response to Norepinephrine Challenge in Diet-Induced Obese Rats. Can J Physiol Pharmacol 87:196-202
28. Habecker BA, Willison BD, Shi X, Woodward WR (2006) Chronic depolarization stimulates norepinephrine transporter expression via catecholamines. J Neurochem 97:1044-1051
29. Haka MS, Kilbourn MR (1989) Synthesis and regional mouse brain distribution of [11C]nisoxetine, a norepinephrine uptake inhibitor. Int J Rad Appl Instrum B 16:771-774
30. Imahori Y, Fujii R, Ueda S, Matsumoto K, Wakita K, Ido T, Nariai T, Nakahashi H (1992) Membrane trapping of carbon-11-labeled 1,2-diacylglycerols as a basic concept for assessing phosphatidylinositol turnover in neurotransmission process. J Nucl Med 33:413-422
31. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 55:2212-2221
32. Jakobsen S, Kodahl GM, Olsen AK, Cumming P (2006) Synthesis, radiolabeling and in vivo evaluation of [11C]RAL-01, a potential phosphodiesterase 5 radioligand. Nucl Med Biol 33:593-597
33. Jaques S Jr, Tobes MC, Sisson JC (1987) Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptakeone. Cancer Res 47:3920-3928
34. Johnson TA, Gray AL, Lauenstein JM, Newton SS, Massari VJ (2004) Parasympathetic control of the heart. I An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles. J Appl Physiol 96:2265-2272
35. Jung CH, Yang YS, Kim JS, Shin JI, Jin YS, Shin JY, Lee JH, Chung KM, Hwang JS, Oh JM, Shin YK, Kweon DH (2008) A search for synthetic peptides that inhibit soluble N-ethylmaleimide sensitive-factor attachment receptor-mediated membrane fusion. FEBS J 275:3051-3063
36. Kagaya Y, Chida M, Imahori Y, Fujii R, Namiuchi S, Takeda M, Yamane Y, Otani H, Watanabe J, Fukuchi M, Tezuka F, Ido T, Shirato K (2002) Effect of angiotensin converting enzyme inhibition on myocardial phosphoinositide metabolism visualised with 1-[1-11C]-butyryl-2-palmitoyl-rac-glycerol in myocardial infarction in the rat. Eur J Nucl Med Mol Imaging 29:1516-1522
37. Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, Ichikawa S, Matsumoto N, Sato Y, Kurabayashi M (2011) Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction. Heart 97:20-26
38. Keller NR, Diedrich A, Appalsamy M, Tuntrakool S, Lonce S, Finney C, Caron MG, Robertson D (2004) Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity. Circulation 110:1191-1196
39. Kenk M, Greene M, Thackeray J, Dekemp RA, Lortie M, Thorn S, Beanlands RS, Dasilva JN (2007) In vivo selective binding of (R)-[(11)C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues. Nucl Med Biol 34:71-77
40. Kenk M, Greene M, Lortie M, Dekemp RA, Beanlands RS, Dasilva JN (2008) Use of a columnswitching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues. Nucl Med Biol 35:515-521
41. Kenk M, Thackeray JT, Thorn SL, Dhami K, Chow BJ, Ascah KJ, Dasilva JN, Beanlands RS (2010) Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin- induced cardiotoxicity. J Nucl Cardiol 17:175-176
42. Kiesewetter DO, Sassaman MB, Robbins J, Elaine MJ, Carson RE, Appel NM, Sutkowski E, Herscovitch P, Braun A, Eckelman WC (2000) Synthesis and evaluation of an 18F analog of forskolin for imaging adenylyl cyclase. J Fluorine Chem 101:297-304
43. Kopin IJ, Gordon EK (1963) Origin of norepinephrine in the heart. Nature 199:1289
44. Law MP, Osman S, Davenport RJ, Cunningham VJ, Pike VW, Camici PG (1997) Biodistribution and metabolism of [N-methyl-11C]m-hydroxyephedrine in the rat. Nucl Med Biol 24:417-424
45. Law MP, Osman S, Pike VW, Davenport RJ, Cunningham VJ, Rimoldi O, Rhodes CG, Giardina D, Camici PG (2000) Evaluation of [11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography. Eur J Nucl Med 27:7-17
46. Law MP, Schafers K, Kopka K, Wagner S, Schober O, Schafers M (2010) Molecular imaging of cardiac sympathetic innervation by 11C-mHED and PET: from man to mouse? J Nucl Med 51:1269-1276
47. Lazewatsky J, Sinusas A, Brunetti J, Heller G, Sparks R, Puretskiy A, Lee LV (2010) Radiation dosimetry of LMI1195, first-in-human study of a novel F-18 labeled tracer for imaging myocardial innervation (Abstract). J Nucl Med 51:1432
48. Li W, Knowlton D, Van Winkle DM, Habecker BA (2004) Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons. Am J Physiol Heart Circ Physiol 286:H2229-H2236
49. Liang CS, Fan TH, Sullebarger JT, Sakamoto S (1989) Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta- adrenoceptor downregulation. J Clin Invest 84:1267-1275
50. Link JM, Synovec RE, Krohn KA, Caldwell JH (1997) High speed liquid chromatography of phenylethanolamines for the kinetic analysis of [11C]-meta-hydroxyephedrine and metabolites in plasma. J Chromatogr B Biomed Sci Appl 693:31-41
51. Lortie M, DaSilva JN, Kenk M, Thorn S, Davis D, Birnie D, Beanlands RS, deKemp RA (2012) Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET. Mol Imaging Biol 14:225-236
52. Lourenco CM, Kenk M, Beanlands RS, DaSilva JN (2006) Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C] rolipram in rat brain, lung and heart. Life Sci 79:356-364
53. Mao W, Iwai C, Qin F, Liang CS (2005) Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress. Am J Physiol Heart Circ Physiol 288:H2381-H2389
54. Mardon K, Montagne O, Elbaz N, Malek Z, Syrota A, Dubois-Rande JL, Meignan M, Merlet P (2003) Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. J Nucl Med 44:1459-1466
55. Matsunari I, Aoki H, Nomura Y, Takeda N, Chen WP, Taki J, Nakajima K, Nekolla SG, Kinuya S, Kajinami K (2010) Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging 3:595-603
56. Miner LH, Schroeter S, Blakely RD, Sesack SR (2003) Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J Comp Neurol 466:478-494
57. Momose M, Reder S, Raffel DM, Watzlowik P, Wester HJ, Nguyen N, Elsinga PH, Bengel FM, Remien J, Schwaiger M (2004) Evaluation of cardiac beta-adrenoreceptors in the isolated perfused rat heart using (S)-11C-CGP12388. J Nucl Med 45:471-477
58. Munch G, Nguyen NT, Nekolla S, Ziegler S, Muzik O, Chakraborty P, Wieland DM, Schwaiger M (2000) Evaluation of sympathetic nerve terminals with [(11)C]epinephrine and [(11)C] hydroxyephedrine and positron emission tomography. Circulation 101:516-523
59. Nakajo M, Shapiro B, Glowniak J, Sisson JC, Beierwaltes WH (1983) Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 24:1127-1134
60. Narula J, Sarkar K (2003) A conceptual paradox of MIBG uptake in heart failure: retention with incontinence! J Nucl Cardiol 10:700-704
61. Naya M, Tsukamoto T, Morita K, Katoh C, Nishijima K, Komatsu H, Yamada S, Kuge Y, Tamaki N, Tsutsui H (2009) Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy. J Nucl Med 50:220-225
62. Nguyen NT, DeGrado TR, Chakraborty P, Wieland DM, Schwaiger M (1997) Myocardial kinetics of carbon-11-epinephrine in the isolated working rat heart. J Nucl Med 38:780-785
63. Nishijima K, Kuge Y, Seki K, Ohkura K, Motoki N, Nagatsu K, Tanaka A, Tsukamoto E, Tamaki N (2002) A simplified and improved synthesis of [11C]phosgene with iron and iron (III) oxide. Nucl Med Biol 29:345-350
64. Nishijima K, Kuge Y, Seki K, Ohkura K, Morita K, Nakada K, Tamaki N (2004) Preparation and pharmaceutical evaluation for clinical application of high specific activity S-(-)[11C]CGP-12177, a radioligand for beta-adrenoreceptors. Nucl Med Commun 25:845-849
65. Otani H, Kagaya Y, Imahori Y, Yasuda S, Fujii R, Chida M, Namiuchi S, Takeda M, Sakuma M, Watanabe J, Ido T, Nonogi H, Shirato K (2005) Myocardial 11C-diacylglycerol accumulation and left ventricular remodeling in patients after myocardial infarction. J Nucl Med 46:553-559
66. Pardini BJ, Lund DD, Schmid PG (1989) Organization of the sympathetic postganglionic innervation of the rat heart. J Auton Nerv Syst 28:193-201
67. Park-Holohan SJ, Asselin MC, Turton DR, Williams SL, Hume SP, Camici PG, Rimoldi OE (2008) Quantification of [11C]GB67 binding to cardiac alpha1-adrenoceptors with positron emission tomography: validation in pigs. Eur J Nucl Med Mol Imaging 35:1624-1635
68. Parrish DC, Gritman K, Van Winkle DM, Woodward WR, Bader M, Habecker BA (2008) Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am J Physiol Heart Circ Physiol 294:H99-H106
69. Raffel DM, Chen W (2004) Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies. Naunyn Schmiedebergs Arch Pharmacol 370:9-16
70. Raffel DM, Wieland DM (2001) Assessment of cardiac sympathetic nerve integrity with positron emission tomography. Nucl Med Biol 28:541-559
71. Raffel DM, Corbett JR, del Rosario RB, Gildersleeve DL, Chiao PC, Schwaiger M, Wieland DM (1996) Clinical evaluation of carbon-11-phenylephrine: MAO-sensitive marker of cardiac sympathetic neurons. J Nucl Med 37:1923-1931
72. Raffel DM, Chen W, Sherman PS, Gildersleeve DL, Jung YW (2006) Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density. J Nucl Med 47:1490-1496
73. Raffel DM, Jung YW, Gildersleeve DL, Sherman PS, Moskwa JJ, Tluczek LJ, Chen W (2007) Radiolabeled phenethylguanidines: novel imaging agents for cardiac sympathetic neurons and adrenergic tumors. J Med Chem 50:2078-2088
74. Ren ZG, Porzgen P, Zhang JM, Chen XR, Amara SG, Blakely RD, Sieber-Blum M (2001) Autocrine regulation of norepinephrine transporter expression. Mol Cell Neurosci 17:539-550
75. Rosenspire KC, Haka MS, Van Dort ME, Jewett DM, Gildersleeve DL, Schwaiger M, Wieland DM (1990) Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med 31:1328-1334
76. Russ H, Gliese M, Sonna J, Schomig E (1992) The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+). Naunyn Schmiedebergs Arch Pharmacol 346:158-165
77. Salt PJ (1972) Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur J Pharmacol 20:329-340
78. Sasaki T, Enta A, Nozaki T, Ishii S, Senda M (1993) Carbon-11-forskolin: a ligand for visualization of the adenylate cyclase-related second messenger system. J Nucl Med 34:1944-1948
79. Sasano T, Abraham MR, Chang KC, Ashikaga H, Mills KJ, Holt DP, Hilton J, Nekolla SG, Dong J, Lardo AC, Halperin H, Dannals RF, Marban E, Bengel FM (2008) Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 51:2266-2275
80. Thackeray JT, Beanlands RS, Dasilva JN (2007) Presence of specific 11C-meta-hydroxyephedrine retention in heart, lung, pancreas, and brown adipose tissue. J Nucl Med 48:1733-1740
81. Thackeray JT, Parsa-Nezhad M, Kenk M, Thorn SL, Kolajova M, Beanlands RS, Dasilva JN (2011) Reduced CGP12177 binding to cardiac beta-adrenoceptors in hyperglycemic high-fatdiet-fed, streptozotocin-induced diabetic rats. Nucl Med Biol 38:1059-1066
82. Thackeray JT, Beanlands RS, DaSilva JN (2012) Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging. Am J Nucl Med Mol Imaging 2:319-339
83. Thackeray JT, Renaud JM, Kordos M, Klein R, deKemp RA, Beanlands RS, DaSilva JN (2013) Test-retest repeatability of quantitative cardiac 11C-meta-hydroxyephedrine measurements in rats by small animal positron emission tomography. Nucl Med Biol 40:676-681
84. Thomas AJ, DaSilva JN, Lortie M, Renaud JM, Kenk M, Beanlands RS, deKemp RA (2011) PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart. J Nucl Med 52:263-269
85. Tipre DN, Fox JJ, Holt DP, Green G, Yu J, Pomper M, Dannals RF, Bengel FM (2008) In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat. J Nucl Med 49:1189-1195
86. Tsukamoto T, Morita K, Naya M, Inubushi M, Katoh C, Nishijima K, Kuge Y, Okamoto H, Tsutsui H, Tamaki N (2007) Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy. J Nucl Med 48:1777-1782
87. Van Dort ME, Kim JH, Tluczek L, Wieland DM (1997) Synthesis of 11C-labeled desipramine and its metabolite 2-hydroxydesipramine: potential radiotracers for PET studies of the norepinephrine transporter. Nucl Med Biol 24:707-711
88. Van Waarde A, Meeder JG, Blanksma PK, Brodde O-E, Visser GM, Elsinga PH, Paans AMJ, Vaalburg W, Lie KI (1992) Uptake of radioligands by rat heart and lung in vivo:CGP 12177 does and CGP 26505 does not reflect binding to ß-adrenoceptors. Eur J Pharmacol 222:107-112
89. van Waarde A, Vaalburg W, Doze P, Bosker FJ, Elsinga PH (2004) PET imaging of betaadrenoceptors in human brain: a realistic goal or a mirage? Curr Pharm Des 10:1519-1536
90. Vasdev N, LaRonde FJ, Woodgett JR, Garcia A, Rubie EA, Meyer JH, Houle S, Wilson AA (2008) Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide. Bioorg Med Chem 16:5277-5284
91. Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR (2006) Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci U S A 103:511-518
92. Wehrwein EA, Parker LM, Wright AA, Spitsbergen JM, Novotny M, Babankova D, Swain GM, Habecker BA, Kreulen DL (2008) Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content. Am J Physiol Regul Integr Comp Physiol 295:R857-R863
93. Wong W, Scott JD (2004) AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5:959-970
94. Woolard J, Bennett T, Dunn WR, Heal DJ, Aspley S, Gardiner SM (2004) Acute cardiovascular effects of sibutramine in conscious rats. J Pharmacol Exp Ther 308:1102-1110
95. Yu M, Bozek J, Lamoy M, Guaraldi M, Silva P, Kagan M, Yalamanchili P, Onthank D, Mistry M, Lazewatsky J, Broekema M, Radeke H, Purohit A, Cdebaca M, Azure M, Cesati R, Casebier D, Robinson SP (2011) Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging 4:435-443